Chart Your Course

APRIL 6, 2015

The top items on their wish list are better pay policies, clearer top-down communication, and greater transparency about pay. Pharmaceutical and biotechnology make up the second-largest group with three representatives: Genentech, Amgen and Pfizer. Case Studies/White Papers Finding top talent Hiring Human Resource Management'

White Paper 100

White Paper Company Biotechnology Case Study 100

Harvard Business Review

MARCH 13, 2012

could learn from — is to test policy proposals before rolling them out nationally. When problems surface, the policy can be fine-tuned, modified, and re-tested before it is tried out on a wider scale. policy making. One thing that the Chinese do quite well — and that the U.S. But not in U.S.

Biotechnology 9

Biotechnology Real Estate Tourism Banking 9

Harvard Business Review

JUNE 4, 2018

For instance, a curriculum designed for a local manufacturer of medical supplies and food safety products includes several courses in electronics, welding, lean, torque certification, robotics/programmable logic controllers, precision machining, and management. “Students need to understand tomorrow’s skills, not yesterday’s.”

Education 8

Education Company Biotechnology Human Capital 8

Harvard Business Review

MARCH 1, 2011

And biotechnology and medical devices are among the leading areas for venture capital funding. Medicare payment policy favors doing more, not doing better. Will hospital managers search for efficiency, or continue to manage volume? Will doctors think about care management as equally valuable as rescue of the sick?

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

MARCH 2, 2012

It started 30 years ago with the progressive and unusual step (for that time) of shifting from local nationals as country managers to global leaders from other countries. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 12

Competitive Advantage Globalization Development Intellectual Capital 12

Harvard Business Review

AUGUST 17, 2015

It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals. And secondly, the business model for Cuban biotechnology has been laughably bad. They’re colossally impressive in the management of politics. We know two things about biotech in Cuba.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. Science and engineering have become devalued amongst American students and policy-makers. It pledges $1.5 Technology belongs on that list as well.

First-mover Advantage 8

First-mover Advantage GDP Technology Biotechnology 8